Nachrichten zur TG Therapeutics Aktie

TG Therapeutics to Participate in the Evercore HealthCONx Conference

Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ET Fireside chat scheduled for Tuesday, December 3, 2024,…

TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript

…

TD Cowen sieht 102 % Kurspotenzial für TG Therapeutics Inc. (TGTX)

TG Therapeutics Inc. (TGTX) ist ein biopharmazeutisches Unternehmen, das sich auf innovative Therapien zur Behandlung von Autoimmun- und Krebserkrankungen spezialisiert…

TG Therapeutics: Die Briumvi Wachstumsstory bleibt durch neue Daten intakt

TG Therapeutics beschäftigt sich mit dem Erwerb, der Entwicklung und Vermarktung neuartiger Behandlungen für B-Zell-Malignome und Autoimmunerkrankungen. Das Unternehmen…

TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval

…

Stocks Strengthen; These IPOs Stand Out

TG Therapeutics cruised past a 23.12 alternative entry.…

TG Therapeutics: Pressure On Briumvi To Perform As Share Price Hits Resistance

…

June 2024 New Analysts Cover Uber, TG Therapeutics, CarMax, And More

…

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

Fireside chat scheduled for Wednesday, June 5, 2024, at 1:30 PM ET Fireside chat scheduled for Wednesday, June 5, 2024,…

TG Therapeutics: Less Room For Doubt About Briumvi

…

Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi By Investing.com

Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi…

TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript

…

G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript

…

TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update

Conference call to be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET Conference call to be held tomorrow,…

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of…

G1 Therapeutics, Inc. (GTHX) Q4 2023 Earnings Call Transcript

…

TG Therapeutics, Inc. (TGTX) Q4 2023 Earnings Call Transcript

…

TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update

Conference call to be held Wednesday, February 28, 2024, at 8:30 AM ET Conference call to be held Wednesday, February…

Precision BioSciences secures $17.5 million from TG Therapeutics By Investing.com

Precision BioSciences secures $17.5 million from TG Therapeutics…

TG Therapeutics: Inferred Expectations Point To Undervalued Shares

…

TG Therapeutics: Indications Of Slowing Market Growth For Briumvi

…

TG Therapeutics prelim results sees FY23 BRIUMVI U.S. revenue $89M; initiates FY24 outlook

…

TG Therapeutics agrees to purchase a global license to a Car T cell therapy program for autoimmune diseases

…

TG Therapeutics spikes; to present at J. P. Morgan conference

…

TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Presentation scheduled for Tuesday, January 9, 2024, at 4:30 PM PT Presentation scheduled for Tuesday, January 9, 2024, at 4:30…

TG Therapeutics: The Revenue Beat Isnt What It Looks Like

…

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology…

TG Therapeutics: Trying To Fill The Gap Back To $20

…

TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Fireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ET Fireside chat scheduled for Wednesday, November 29, 2023,…

XFRA ISIN CHANGE

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen US9183851057 vTv Therapeutics Inc. 20.11.2023 US9183852048 vTv Therapeutics…

TG Therapeutics, Inc. (TGTX) Q3 2023 Earnings Call Transcript

…

TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference

Fireside chat scheduled for Monday, November 6, 2023, at 3:10 PM ET Fireside chat scheduled for Monday, November 6, 2023,…

TG Therapeutics: Q3 Earnings Spike Hard To Explain Given Rivals Numbers

…

G1 Therapeutics, Inc. (GTHX) Q3 2023 Earnings Call Transcript

…

TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business Update

Conference call to be held Wednesday, November 1, 2023, at 8:30 AM ET Conference call to be held Wednesday, November…

TG Therapeutics: Things Are Stacking Up Against Briumvi

…

TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

NEW YORK, Oct. 12, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the presentation of data…

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations,…

dpa-AFX ProFeed